Imprimis NJOF, LLC is recalling 3,320 bottles of Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution (1%, 0.5%, 0.075%). This medication is being recalled because it was found to be subpotent, which means it contains less than the required amount of active ingredients. The affected bottles are 8mL in size and were compounded by Imprimis NJOF, LLC in Ledgewood, New Jersey.
A subpotent drug may not work as effectively as intended, potentially failing to treat the underlying condition for which it was prescribed. This could lead to inadequate management of inflammation or infection in the eye.
You have 2 options:
Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.